Which has stronger valuation & earnings, MIR or ALNT?

Mirion Technologies has higher revenue and earnings than Allient. Allient is trading at a lower price-to-earnings ratio than Mirion Technologies, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Mirion Technologies $925.40M 4.67 $28.80M $0.10 172.63 Allient $554.48M 2.67 $22.03M $1.43 60.97

Does the media refer more to MIR or ALNT?

In the previous week, Mirion Technologies had 1 more articles in the media than Allient. MarketBeat recorded 5 mentions for Mirion Technologies and 4 mentions for Allient. Mirion Technologies' average media sentiment score of 0.89 beat Allient's score of 0.20 indicating that Mirion Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mirion Technologies 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Allient 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation and earnings, VNT or ALNT?

Vontier has higher revenue and earnings than Allient. Vontier is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Vontier $3.08B 1.30 $406.10M $2.83 10.03 Allient $554.48M 2.67 $22.03M $1.43 60.97

Is VNT or ALNT more profitable?

Vontier has a net margin of 13.37% compared to Allient's net margin of 4.25%. Vontier's return on equity of 37.88% beat Allient's return on equity. Company Net Margins Return on Equity Return on Assets Vontier 13.37% 37.88% 10.90% Allient 4.25% 12.47% 6.37%

Does the media refer more to VNT or ALNT?

In the previous week, Vontier and Vontier both had 4 articles in the media. Vontier's average media sentiment score of 0.71 beat Allient's score of 0.20 indicating that Vontier is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vontier 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Allient 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings & valuation, ALNT or TXG?

Allient has higher earnings, but lower revenue than 10x Genomics. 10x Genomics is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Allient $554.48M 2.67 $22.03M $1.43 60.97 10x Genomics $642.82M 5.76 -$43.54M -$0.17 N/A

Is ALNT or TXG more profitable?

Allient has a net margin of 4.25% compared to 10x Genomics' net margin of -3.55%. Allient's return on equity of 12.47% beat 10x Genomics' return on equity. Company Net Margins Return on Equity Return on Assets Allient 4.25% 12.47% 6.37% 10x Genomics -3.55% -2.86% -2.23%

Does the media favor ALNT or TXG?

In the previous week, Allient had 1 more articles in the media than 10x Genomics. MarketBeat recorded 4 mentions for Allient and 3 mentions for 10x Genomics. 10x Genomics' average media sentiment score of 1.03 beat Allient's score of 0.20 indicating that 10x Genomics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Allient 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral 10x Genomics 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, ALNT or AEHR?

Allient has higher revenue and earnings than Aehr Test Systems. Aehr Test Systems is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Allient $554.48M 2.67 $22.03M $1.43 60.97 Aehr Test Systems $58.97M 50.97 -$3.91M -$0.38 N/A

Does the media favor ALNT or AEHR?

In the previous week, Aehr Test Systems had 3 more articles in the media than Allient. MarketBeat recorded 7 mentions for Aehr Test Systems and 4 mentions for Allient. Aehr Test Systems' average media sentiment score of 0.64 beat Allient's score of 0.20 indicating that Aehr Test Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Allient 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aehr Test Systems 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, ALNT or ALMR?

Allient has higher revenue and earnings than Alamar Biosciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Allient $554.48M 2.67 $22.03M $1.43 60.97 Alamar Biosciences $87.16M 15.28 N/A N/A N/A

Does the media prefer ALNT or ALMR?

In the previous week, Allient had 2 more articles in the media than Alamar Biosciences. MarketBeat recorded 4 mentions for Allient and 2 mentions for Alamar Biosciences. Alamar Biosciences' average media sentiment score of 0.36 beat Allient's score of 0.20 indicating that Alamar Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Allient 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Alamar Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Allient (ALNT) Competitors

$87.18 +2.32 (+2.73%)

Closing price 04:00 PM Eastern

Extended Trading

$87.28 +0.09 (+0.11%)

As of 07:15 PM Eastern

Compare

ALNT vs. MIR, VNT, TXG, AEHR, and ALMR

Should you buy Allient stock or one of its competitors? MarketBeat compares Allient with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Allient include Mirion Technologies (MIR), Vontier (VNT), 10x Genomics (TXG), Aehr Test Systems (AEHR), and Alamar Biosciences (ALMR). These companies are all part of the "measuring and control equipment" industry.

How does Allient compare to Mirion Technologies?

Mirion Technologies (NYSE:MIR) and Allient (NASDAQ:ALNT) are both measuring and control equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation and risk.

In the previous week, Mirion Technologies had 1 more articles in the media than Allient. MarketBeat recorded 5 mentions for Mirion Technologies and 4 mentions for Allient. Mirion Technologies' average media sentiment score of 0.89 beat Allient's score of 0.20 indicating that Mirion Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mirion Technologies	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Allient	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Allient has a net margin of 4.25% compared to Mirion Technologies' net margin of 2.56%. Allient's return on equity of 12.47% beat Mirion Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mirion Technologies	2.56%	6.44%	3.48%
Allient	4.25%	12.47%	6.37%

Mirion Technologies has higher revenue and earnings than Allient. Allient is trading at a lower price-to-earnings ratio than Mirion Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mirion Technologies	$925.40M	4.67	$28.80M	$0.10	172.63
Allient	$554.48M	2.67	$22.03M	$1.43	60.97

Mirion Technologies presently has a consensus target price of $27.13, indicating a potential upside of 57.13%. Allient has a consensus target price of $77.33, indicating a potential downside of 11.29%. Given Mirion Technologies' stronger consensus rating and higher probable upside, research analysts plainly believe Mirion Technologies is more favorable than Allient.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mirion Technologies	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.80
Allient	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

Mirion Technologies has a beta of 1.03, indicating that its share price is 3% more volatile than the broader market. Comparatively, Allient has a beta of 1.64, indicating that its share price is 64% more volatile than the broader market.

78.5% of Mirion Technologies shares are held by institutional investors. Comparatively, 61.6% of Allient shares are held by institutional investors. 2.2% of Mirion Technologies shares are held by insiders. Comparatively, 15.0% of Allient shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Mirion Technologies beats Allient on 11 of the 17 factors compared between the two stocks.

How does Allient compare to Vontier?

Vontier (NYSE:VNT) and Allient (NASDAQ:ALNT) are both measuring and control equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, institutional ownership and media sentiment.

In the previous week, Vontier and Vontier both had 4 articles in the media. Vontier's average media sentiment score of 0.71 beat Allient's score of 0.20 indicating that Vontier is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vontier	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Allient	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Vontier has a net margin of 13.37% compared to Allient's net margin of 4.25%. Vontier's return on equity of 37.88% beat Allient's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vontier	13.37%	37.88%	10.90%
Allient	4.25%	12.47%	6.37%

Vontier pays an annual dividend of $0.10 per share and has a dividend yield of 0.4%. Allient pays an annual dividend of $0.16 per share and has a dividend yield of 0.2%. Vontier pays out 3.5% of its earnings in the form of a dividend. Allient pays out 11.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Vontier is clearly the better dividend stock, given its higher yield and lower payout ratio.

95.8% of Vontier shares are held by institutional investors. Comparatively, 61.6% of Allient shares are held by institutional investors. 1.1% of Vontier shares are held by company insiders. Comparatively, 15.0% of Allient shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Vontier has a beta of 1.16, suggesting that its stock price is 16% more volatile than the broader market. Comparatively, Allient has a beta of 1.64, suggesting that its stock price is 64% more volatile than the broader market.

Vontier currently has a consensus target price of $42.38, suggesting a potential upside of 49.21%. Allient has a consensus target price of $77.33, suggesting a potential downside of 11.29%. Given Vontier's higher probable upside, research analysts plainly believe Vontier is more favorable than Allient.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vontier	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.40
Allient	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

Vontier has higher revenue and earnings than Allient. Vontier is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vontier	$3.08B	1.30	$406.10M	$2.83	10.03
Allient	$554.48M	2.67	$22.03M	$1.43	60.97

Summary

Vontier beats Allient on 12 of the 17 factors compared between the two stocks.

How does Allient compare to 10x Genomics?

Allient (NASDAQ:ALNT) and 10x Genomics (NASDAQ:TXG) are both measuring and control equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, media sentiment, earnings and analyst recommendations.

Allient has a net margin of 4.25% compared to 10x Genomics' net margin of -3.55%. Allient's return on equity of 12.47% beat 10x Genomics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Allient	4.25%	12.47%	6.37%
10x Genomics	-3.55%	-2.86%	-2.23%

Allient currently has a consensus target price of $77.33, indicating a potential downside of 11.29%. 10x Genomics has a consensus target price of $23.17, indicating a potential downside of 20.61%. Given Allient's stronger consensus rating and higher possible upside, research analysts plainly believe Allient is more favorable than 10x Genomics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allient	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
10x Genomics	1 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.20

61.6% of Allient shares are owned by institutional investors. Comparatively, 84.7% of 10x Genomics shares are owned by institutional investors. 15.0% of Allient shares are owned by company insiders. Comparatively, 8.8% of 10x Genomics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Allient has higher earnings, but lower revenue than 10x Genomics. 10x Genomics is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allient	$554.48M	2.67	$22.03M	$1.43	60.97
10x Genomics	$642.82M	5.76	-$43.54M	-$0.17	N/A

Allient has a beta of 1.64, meaning that its share price is 64% more volatile than the broader market. Comparatively, 10x Genomics has a beta of 2.12, meaning that its share price is 112% more volatile than the broader market.

In the previous week, Allient had 1 more articles in the media than 10x Genomics. MarketBeat recorded 4 mentions for Allient and 3 mentions for 10x Genomics. 10x Genomics' average media sentiment score of 1.03 beat Allient's score of 0.20 indicating that 10x Genomics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Allient	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
10x Genomics	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Allient beats 10x Genomics on 10 of the 15 factors compared between the two stocks.

How does Allient compare to Aehr Test Systems?

Allient (NASDAQ:ALNT) and Aehr Test Systems (NASDAQ:AEHR) are both computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation, risk and media sentiment.

61.6% of Allient shares are held by institutional investors. Comparatively, 69.7% of Aehr Test Systems shares are held by institutional investors. 15.0% of Allient shares are held by insiders. Comparatively, 6.8% of Aehr Test Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Aehr Test Systems had 3 more articles in the media than Allient. MarketBeat recorded 7 mentions for Aehr Test Systems and 4 mentions for Allient. Aehr Test Systems' average media sentiment score of 0.64 beat Allient's score of 0.20 indicating that Aehr Test Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Allient	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aehr Test Systems	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Allient has a beta of 1.64, indicating that its share price is 64% more volatile than the broader market. Comparatively, Aehr Test Systems has a beta of 3.18, indicating that its share price is 218% more volatile than the broader market.

Allient currently has a consensus price target of $77.33, suggesting a potential downside of 11.29%. Aehr Test Systems has a consensus price target of $68.00, suggesting a potential downside of 28.86%. Given Allient's stronger consensus rating and higher possible upside, analysts clearly believe Allient is more favorable than Aehr Test Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allient	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
Aehr Test Systems	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Allient has a net margin of 4.25% compared to Aehr Test Systems' net margin of -25.23%. Allient's return on equity of 12.47% beat Aehr Test Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Allient	4.25%	12.47%	6.37%
Aehr Test Systems	-25.23%	-7.15%	-6.15%

Allient has higher revenue and earnings than Aehr Test Systems. Aehr Test Systems is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allient	$554.48M	2.67	$22.03M	$1.43	60.97
Aehr Test Systems	$58.97M	50.97	-$3.91M	-$0.38	N/A

Summary

Allient beats Aehr Test Systems on 11 of the 16 factors compared between the two stocks.

How does Allient compare to Alamar Biosciences?

Allient (NASDAQ:ALNT) and Alamar Biosciences (NASDAQ:ALMR) are both small-cap measuring and control equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

Allient has higher revenue and earnings than Alamar Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allient	$554.48M	2.67	$22.03M	$1.43	60.97
Alamar Biosciences	$87.16M	15.28	N/A	N/A	N/A

61.6% of Allient shares are held by institutional investors. 15.0% of Allient shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Allient presently has a consensus target price of $77.33, indicating a potential downside of 11.29%. Alamar Biosciences has a consensus target price of $30.00, indicating a potential upside of 56.17%. Given Alamar Biosciences' higher probable upside, analysts clearly believe Alamar Biosciences is more favorable than Allient.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allient	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
Alamar Biosciences	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

In the previous week, Allient had 2 more articles in the media than Alamar Biosciences. MarketBeat recorded 4 mentions for Allient and 2 mentions for Alamar Biosciences. Alamar Biosciences' average media sentiment score of 0.36 beat Allient's score of 0.20 indicating that Alamar Biosciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Allient	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alamar Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Allient has a net margin of 4.25% compared to Alamar Biosciences' net margin of 0.00%. Allient's return on equity of 12.47% beat Alamar Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Allient	4.25%	12.47%	6.37%
Alamar Biosciences	N/A	N/A	N/A

Summary

Allient beats Alamar Biosciences on 7 of the 10 factors compared between the two stocks.

Get Allient News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALNT vs. The Competition

Export

Metric	Allient	ELEC Industry	Computer Sector	NASDAQ Exchange
Market Cap	$1.44B	$7.82B	$38.95B	$11.99B
Dividend Yield	0.19%	1.51%	3.14%	5.57%
P/E Ratio	60.97	48.26	164.37	21.95
Price / Sales	2.67	4.02	637.23	108.00
Price / Cash	23.07	29.93	48.75	37.25
Price / Book	4.90	4.31	9.71	6.78
Net Income	$22.03M	$191.44M	$1.07B	$337.51M
7 Day Performance	4.94%	-3.69%	-3.08%	-2.72%
1 Month Performance	30.72%	10.68%	4.38%	1.87%
1 Year Performance	173.29%	76.97%	159.73%	26.61%

Allient Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALNT Allient	3.9243 of 5 stars	$87.18 +2.7%	$77.33 -11.3%	+166.0%	$1.44B	$554.48M	60.97	2,478	Gap Up
MIR Mirion Technologies	4.0762 of 5 stars	$18.03 +1.2%	$27.13 +50.4%	-14.5%	$4.52B	$981M	180.31	3,281
VNT Vontier	4.0692 of 5 stars	$28.39 -0.3%	$42.38 +49.3%	-22.0%	$4.00B	$3.09B	10.03	7,800	News Coverage
TXG 10x Genomics	1.5079 of 5 stars	$30.71 +3.8%	$23.17 -24.6%	+229.5%	$3.90B	$638.78M	N/A	1,240	Positive News
AEHR Aehr Test Systems	1.3589 of 5 stars	$113.00 +20.7%	$68.00 -39.8%	+768.2%	$3.55B	$58.97M	N/A	90	Analyst Upgrade Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ALNT) was last updated on 6/8/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Allient (ALNT) Competitors

ALNT vs. MIR, VNT, TXG, AEHR, and ALMR

How does Allient compare to Mirion Technologies?

Summary

How does Allient compare to Vontier?

Summary

How does Allient compare to 10x Genomics?

Summary

How does Allient compare to Aehr Test Systems?

Summary

How does Allient compare to Alamar Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALNT vs. The Competition

Allient Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Allient (ALNT) Competitors

ALNT vs. MIR, VNT, TXG, AEHR, and ALMR

How does Allient compare to Mirion Technologies?

Does the media refer more to MIR or ALNT?

Is MIR or ALNT more profitable?

Which has stronger valuation & earnings, MIR or ALNT?

Do analysts prefer MIR or ALNT?

Which has more volatility & risk, MIR or ALNT?

Do insiders & institutionals have more ownership in MIR or ALNT?

Summary

How does Allient compare to Vontier?

Does the media refer more to VNT or ALNT?

Is VNT or ALNT more profitable?

Is VNT or ALNT a better dividend stock?

Do insiders & institutionals have more ownership in VNT or ALNT?

Which has more risk and volatility, VNT or ALNT?

Do analysts recommend VNT or ALNT?

Which has preferable valuation and earnings, VNT or ALNT?

Summary

How does Allient compare to 10x Genomics?

Is ALNT or TXG more profitable?

Do analysts rate ALNT or TXG?

Do institutionals and insiders believe in ALNT or TXG?

Which has higher earnings & valuation, ALNT or TXG?

Which has more volatility & risk, ALNT or TXG?

Does the media favor ALNT or TXG?

Summary

How does Allient compare to Aehr Test Systems?

Do institutionals & insiders have more ownership in ALNT or AEHR?

Does the media favor ALNT or AEHR?

Which has more volatility & risk, ALNT or AEHR?

Do analysts prefer ALNT or AEHR?

Is ALNT or AEHR more profitable?

Which has higher valuation & earnings, ALNT or AEHR?

Summary

How does Allient compare to Alamar Biosciences?

Which has preferable valuation and earnings, ALNT or ALMR?

Do institutionals & insiders have more ownership in ALNT or ALMR?

Do analysts prefer ALNT or ALMR?

Does the media prefer ALNT or ALMR?

Is ALNT or ALMR more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALNT vs. The Competition

Allient Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools